KDM5A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.329200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.487800E-01
Normal-vs-Stage2
6.086800E-01
Normal-vs-Stage3
1.104820E-01
Normal-vs-Stage4
9.860800E-01
Stage1-vs-Stage2
3.161000E-01
Stage1-vs-Stage3
1.250380E-01
Stage1-vs-Stage4
1.174360E-01
Stage2-vs-Stage3
1.053650E-02
Stage2-vs-Stage4
5.657600E-01
Stage3-vs-Stage4
2.498000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.628600E-01
Normal-vs-AfricanAmerican
5.875600E-01
Normal-vs-Asian
1.512020E-01
Caucasian-vs-AfricanAmerican
8.412400E-01
Caucasian-vs-Asian
3.396800E-01
AfricanAmerican-vs-Asian
2.050200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.882400E-01
Normal-vs-Female
2.152400E-01
Male-vs-Female
2.602200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.397400E-01
Normal-vs-Age(41-60Yrs)
5.466600E-01
Normal-vs-Age(61-80Yrs)
5.636200E-01
Normal-vs-Age(81-100Yrs)
1.642200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.310090E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.337000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.368800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.916400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.509240E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.353800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.497000E-01
Normal-vs-Daily Drinker
1.301220E-01
Normal-vs-Weekly Drinker
1.178800E-01
Normal-vs-Occasional Drinker
5.742000E-01
Normal-vs-Social Drinker
6.311800E-01
Non Drinker-vs-Daily Drinker
4.314000E-01
Non Drinker-vs-Weekly Drinker
3.811800E-01
Non Drinker-vs-Occasional Drinker
2.863600E-01
Non Drinker-vs-Social Drinker
3.647400E-01
Daily Drinker-vs-Weekly Drinker
8.525000E-01
Daily Drinker-vs-Occasional Drinker
9.192100E-02
Daily Drinker-vs-Social Drinker
1.503440E-01
Weekly Drinker-vs-Occasional Drinker
9.585700E-02
Weekly Drinker-vs-Social Drinker
1.605380E-01
Occasional Drinker-vs-Social Drinker
9.815200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.582800E-01
Normal-vs-Grade 2
1.801440E-01
Normal-vs-Grade 3
9.704900E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.552000E-01
Grade 1-vs-Grade 3
9.523600E-01
Grade 1-vs-Grade 4
2.582800E-01
Grade 2-vs-Grade 3
6.743400E-01
Grade 2-vs-Grade 4
1.801440E-01
Grade 3-vs-Grade 4
9.704900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.095800E-01
Normal-vs-NonDiabetic
4.784600E-01
Diabetic-vs-NonDiabetic
7.484400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.016400E-01
Normal-vs-NoPancreatitis
4.575800E-01
Pancreatitis-vs-NoPancreatitis
8.880800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.866600E-01
Normal-vs-N1
6.248200E-01
N0-vs-N1
3.170000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.634600E-01
Normal-vs-TP53-NonMutant
6.019400E-01
TP53-Mutant-vs-TP53-NonMutant
3.818200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
